Should I Invest In Unilever plc Now?

Can Unilever plc (LON: ULVR) still deliver a decent investment return?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UnileverConsumer goods company Unilever (LSE: ULVR) (NYSE: UL.US) is big and successful, but that’s not going to stop the firm nipping and tucking its operations to keep forward progress vibrant.

Managements run the best businesses as active organisations, constantly responding to market changes and evolving to optimise their shifting opportunities. Just because a firm gets big doesn’t mean that it has to stagnate like the conglomerates of yesteryear.

Sharper focus on foods

Unilever’s recently announced intention to dispose of its low-margin US pasta business is a good example. Ditching the well-loved Ragu and Bertolli brands, the leading pasta sauce brands in North America, will raise $2.15 billion, and the directors expect to dust the deal by the end of June.

The firm has been streamlining its portfolio in the US for some time and describes this latest move as one of the final steps. The prize is a sharpened focus on the foods business, which the company expects to help deliver sustainable growth for Unilever.

Fast-growing markets

Progress across the pond is encouraging but the real excitement for investors is the firm’s perky looking penetration into emerging markets. About 57% of Unilever’s revenue came from up-and-coming markets last year and, if high single figure growth rates continue, it won’t be many years before results in emerging markets will dominate the share-price performance.

Latin America, Asia and Africa are all important regions for the firm and, long term, the outlook for those economies remains compelling despite short-term jitters. Unilever’s CEO reckons the firm is making sound progress transforming itself into a sustainable-growth company despite on-going trading headwinds and fierce competition in both developed and emerging markets, citing underlying sales growth and strong cash flow as good forward indicators. It’s tempting to imagine the firm’s sharp focus on costs and product evolution leading to higher growth rates if the macro-economic environment continues to improve worldwide.

Valuation

That’s exactly what investors seem to be doing and the firm’s valuation seems full. At today’s share price of 2,682p, the forward P/E rating is running at almost 19 for 2015 and the forward dividend yield is around 3.7%. City analysts following the firm expect earnings to grow about 8% that year.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin does not own any Unilever shares. The Motley Fool has recommended Unilever.

More on Investing Articles

Happy young female stock-picker in a cafe
Investing Articles

Q1 results boost the Bunzl share price: investors should consider the stock for stability

As the Bunzl share price edges higher, our writer considers whether this so-called boring FTSE 100 stock looks like a…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

The top 5 investment trusts to buy in a resurgent UK stock market?

These were the five most popular investment trusts at Hargreaves Lansdown in April. And they're not the ones I'd have…

Read more »

woman sitting in wheelchair at the table and looking at computer monitor while talking on mobile phone and drinking coffee at home
Investing Articles

The smartest dividend stocks to consider buying with £500 right now

In the past few years, the UK stock market’s been a great place to find dividend stocks paying top yields.…

Read more »

2024 year number handwritten on a sandy beach at sunrise
Investing Articles

Why this FTSE 100 company is the first I’m buying for my 24/25 Stocks and Shares ISA

As a new Stocks and Shares ISA year gets underway, it’s time to start searching for my next additions. Barclays…

Read more »

Investing Articles

How much passive income would I make from 945 National Grid shares?

National Grid shares pay a healthy dividend that, over time, can produce a sizeable passive income if the dividends are…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

These 7 UK shares turned £50k into £550k

Investing in individual UK shares can be a very lucrative strategy. Over the last two decades, these seven stocks have…

Read more »

Tanker coming in to dock in calm waters and a clear sunset
Investing Articles

Up 14% in a day! Is this embattled FTSE 250 company on the road to recovery?

The sudden price surge in a lesser-known FTSE 250 stock caught my attention today. I decided to find out what’s…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this FTSE growth superstar set to soar even higher on new drug results?

New drugs should significantly boost this FTSE stock’s earnings in my view. But even without them it looked very undervalued…

Read more »